Profile
Yi Pin Huang is the founder of PharmaDax Inc. established in 2008.
Currently, he holds the position of Chairman in PharmaDax USA, Inc., PharmaDax (Hong Kong) Ltd., Ansbach Acoustic International Ltd., and is a Director in Reach High Enterprises Ltd., Master Brand Global Corp., Quantex Holding Ltd.
and a Member-Supervisory Board in Shengqun Pharmaceutical Co., Ltd.
Mr. Huang has a graduate degree from St. John's University and an undergraduate degree from Taipei Medical University.
Yi Pin Huang active positions
| Companies | Position | Start |
|---|---|---|
| PharmaDax USA, Inc. | Chairman | - |
| PharmaDax (Hong Kong) Ltd. | Chairman | - |
| Reach High Enterprises Ltd. | Director/Board Member | - |
| Master Brand Global Corp. | Director/Board Member | - |
| Quantex Holding Ltd. | Director/Board Member | - |
| Ansbach Acoustic International Ltd. | Chairman | - |
| Shengqun Pharmaceutical Co., Ltd. | Director/Board Member | - |
Former positions of Yi Pin Huang
| Companies | Position | End |
|---|---|---|
| PHARMADAX INC. | Founder | - |
Training of Yi Pin Huang
| St. John's University | Graduate Degree |
| Taipei Medical University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
PharmaDax Inc.
 PharmaDax Inc. Pharmaceuticals: MajorHealth Technology PharmaDax Inc. engages in the development and marketing of generic dossiers. Its products include Glyburide, Quetiapine Fumarate ER, and Metoprolol Succinate ER tablets. The company was founded by Yi Pin Huang on March 21, 2008 and is headquartered in New Taipei, Taiwan. | Health Technology |
| PharmaDax USA, Inc. | |
| PharmaDax (Hong Kong) Ltd. | |
| Reach High Enterprises Ltd. | |
| Master Brand Global Corp. | |
| Quantex Holding Ltd. | |
| Ansbach Acoustic International Ltd. | |
| Shengqun Pharmaceutical Co., Ltd. |
- Stock Market
- Insiders
- Yi Pin Huang
